The Musculoskeletal System During Puberty in Dancers With Scoliosis, and the Effect of an Exercise Program

January 30, 2026 updated by: Gali Dar, University of Haifa
assessment of the musculoskeletal system will be performed twice a year, for three years of young dancers

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Objectives: To examine musculoskeletal system characteristics in female dancers with and without scoliosis throughout the pubertal period, and to evaluate the effect of a targeted preventive exercise program.

Methods: Up to 140 female dancers aged 11-16 will be recruited for a two-phase study:

Phase A: a two-year longitudinal study with four assessment time points. . At each time point, participants will complete a comprehensive assessment including: anthropometric measurements (height and weight), sexual maturation status (Tanner scale), scoliosis assessment (Adam's forward bend test, scoliometer measurements, Scoliosis Research Society-22 questionnaire), bone strength (quantitative ultrasound using a Speed of Sound [SOS] device), abdominal and back muscle morphology (ultrasound imaging), hip muscle strength (handheld dynamometry), hip range of motion (goniometry), dynamic balance (Y Balance Test), and flexibility (Beighton score). In addition, participants will complete a demographic questionnaire and an injury surveillance questionnaire.

Phase B : an intervention study in which dancers with scoliosis will be randomly assigned to either a three-month targeted exercise program or a control group continuing regular training. Outcomes will be assessed post-intervention and at one-year follow-up.

Study Type

Interventional

Enrollment (Estimated)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Haifa, Israel
        • Recruiting
        • Haifa University, Department of PHysical Therapy
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Female dancers aged 11-16 years who dance at least three times per week and whose parents have provided informed consent.
  • Dancers who have participated in at least three weekly hours of classical ballet during the year preceding the study and during the study year.
  • A minimum of two years of experience in classical ballet training.
  • Dancers without underlying medical conditions, not taking medications, and with no history of orthopedic surgery.
  • dancers diagnosed during the study with mild to moderate scoliosis who are not under medical follow-up requiring active orthopedic or surgical treatment.

Exclusion criteria:

- Dancers who are taking medications, are not in good health, have underlying medical conditions, or have undergone any orthopedic surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: excercise
exercises for strengthening
exercise for strengthening core muscles
No Intervention: control
regular activity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ultrasound for muscle thickness
Time Frame: baseline, twice a year for 2 years
ultrasound assessment of back and abdominal muscles in rest and contraction - thickness in mm
baseline, twice a year for 2 years
muscle strength test
Time Frame: baseline, twice a year for 2 years
hand held dynamometer assessment hip muscles
baseline, twice a year for 2 years
range of motion
Time Frame: baseline, twice a year for 2 years
goniometer assessment for lower extremities joints
baseline, twice a year for 2 years
bone strength
Time Frame: baseline, twice a year for 2 years
tibia bone strength assessment using Sunlight MiniOmni Ultrasound Bone Sonometer
baseline, twice a year for 2 years
scoliosis
Time Frame: baseline, twice a year for 2 years
Adam's tests and scoliometer
baseline, twice a year for 2 years
maturation status
Time Frame: baseline, twice a year for 2 years
Tanner scale 0-5 scale. higher score represent greater maturation status
baseline, twice a year for 2 years
flexibility
Time Frame: baseline, twice a year for 2 years
Beighton score. 0-9 scale when higher score represent hyper flexibility
baseline, twice a year for 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gali Dar, PhD, University of Haifa

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2026

Primary Completion (Estimated)

August 30, 2028

Study Completion (Estimated)

August 30, 2028

Study Registration Dates

First Submitted

January 23, 2026

First Submitted That Met QC Criteria

January 23, 2026

First Posted (Actual)

January 30, 2026

Study Record Updates

Last Update Posted (Actual)

February 3, 2026

Last Update Submitted That Met QC Criteria

January 30, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

De-identified individual participant data will be shared with other researchers upon reasonable request and in coordination with the principal investigator, subject to ethical approval and data use agreements.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Development, Adolescent

Clinical Trials on exercise

Subscribe